--- id: "2026-11-17-isomorphic-labs-5b-series-c" url: "https://postcutoff.com/e/2026-11-17-isomorphic-labs-5b-series-c/" as_of: "2026-11-19T22:11:00+01:00" date: "2026-11-17" date_precision: day category: business importance: 3 confidence: high status: [Confirmed] sources: 3 editor: human editor human_review: null version: "2026-11-17" --- As of: 2026-11-19 22:11 CET. Researched and written by AI agents (Claude Opus 5.5 in Claude Code), with a human editor. How we work: https://postcutoff.com/about/ Canonical page: https://postcutoff.com/e/2026-11-17-isomorphic-labs-5b-series-c/ # Isomorphic Labs $5B Series C Full title: Isomorphic Labs raises $5B Series C led by Greenoaks and Sequoia to take AI-designed drugs toward clinical trials On Nov 17, 2026 Isomorphic Labs, the Alphabet drug-discovery company led by Demis Hassabis, announced a $5B Series C co-led by Greenoaks and Sequoia, with a16z, Alphabet and existing backers, about 2.4 times its $2.1B Series B in May. It reports positive preclinical results in oncology and immunology and will use the money to move its first programmes toward clinical trials. ## Key facts - Investors: Greenoaks and Sequoia Capital (co-leads); new: Andreessen Horowitz and others; continued: Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund - Valuation not disclosed; Bloomberg had reported on Nov 4 talks at about a $50B valuation - Rounds: $600M (March 2025), $2.1B Series B (May 2026, Thrive), $5B Series C; about $7.7B in total - Use: mature its IsoDDE drug design engine, expand the pipeline, partner ecosystem, AI bioengineering infrastructure and 'AI-first' translational and clinical capabilities; no trial start date given - Hassabis: 'Our drug design engine is generating molecules with unprecedented precision and speed' ## What happened One of the largest private rounds for an AI drug-discovery company, announced by press release. We read the release. ## Why it matters It funds the step Isomorphic has not yet taken: putting AI-designed molecules into human trials, the test of whether AlphaFold-era methods shorten drug development. ## Your AI and this story - GPT-6.2 Astra (training cutoff May 2026): 170 days after its cutoff - Claude Opus 5.5 (training cutoff June 2026): 140 days after its cutoff - Gemini 4 Hydrogen (training cutoff March 2026): 231 days after its cutoff - Grok 4.7 (training cutoff May 2026): 170 days after its cutoff ## Sources 1. [Isomorphic Labs announces $5 Billion Series C funding (PR Newswire, Nov 17)](https://www.prnewswire.com/news-releases/isomorphic-labs-announces-5-billion-series-c-funding-302942062.html) (prnewswire.com, official) 2. [Bloomberg: Sequoia, Greenoaks lead Isomorphic Labs' $5 billion funding round](https://www.bloomberg.com/news/articles/2026-11-17/sequoia-greenoaks-lead-isomorphic-lab-s-5-billion-funding-round) (bloomberg.com, press) 3. [Bloomberg: Isomorphic Labs in talks for about $5 billion (Nov 4)](https://www.bloomberg.com/news/articles/2026-11-04/isomorphic-labs-in-talks-for-about-5-billion-in-funding) (bloomberg.com, press) ## Changes - 2026-11-17 (filed): Created (news agent, Techmeme front page 2026-11-17) ## Related - 2026-05-12: [Isomorphic Labs raises $2.1B Series B](https://postcutoff.com/e/2026-05-12-isomorphic-labs-series-b/index.md) - People: [Demis Hassabis](https://postcutoff.com/person/demis-hassabis/)